All In Biotech

Drug Trial Radar · NCT00003751

Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With Glioblastoma

Phase II Study of Penicillamine and Reduction of Copper for Angiosuppressive Therapy of Adults With Newly Diagnosed Glioblastoma

Last checked: Nov 20, 2026Latest source record: May 3, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

40

Planned (sponsor's estimate)

Start

Mar 1999

Primary completion

Jun 2004

Study completion Jul 2005

Sponsor

Lead sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Cancer Institute (NCI)
First posted
Aug 18, 2004

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Penicillamine may stop the growth of glioblastomas by stopping blood flow to the tumor. A diet low in copper may interfere with the growth of brain tumor cells. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining these therapies may be effective in treating glioblastoma. PURPOSE: Phase II trial to study the effectiveness of penicillamine, a low copper diet, and radiation therapy in treating patients who have newly diagnosed glioblastoma.

Conditions

  • Brain and Central Nervous System Tumors

Interventions

  • penicillamineDrug

  • radiation therapyRadiation

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama Comprehensive Cancer Center

    Birmingham, Alabama

  • H. Lee Moffitt Cancer Center and Research Institute

    Tampa, Florida

  • Emory University School of Medicine

    Atlanta, Georgia

  • Johns Hopkins Oncology Center

    Baltimore, Maryland

  • Massachusetts General Hospital Cancer Center

    Boston, Massachusetts

  • Henry Ford Hospital

    Detroit, Michigan

  • Comprehensive Cancer Center of Wake Forest University Baptist Medical Center

    Winston-Salem, North Carolina

  • University of Pennsylvania Cancer Center

    Philadelphia, Pennsylvania

  • University of Texas Health Science Center at San Antonio

    San Antonio, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.